A Study to Compare the PK, PD and Safety and Tolerability of a SC With an IV Formulation of ARGX-113 in Healthy Male Subjects
Clinical trial NCT03334084 · COMPLETED
Trial details
- NCT number
- NCT03334084
- Sponsor
- argenx
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-10-11
- Primary completion
- 2018-09-19
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.